Recent experience with intrathecal radiogold for medulloblastoma and ependymoblastoma: a progress report.
D000293:Adolescent; D001932:Brain Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D002420:Cauda Equina; D002490:Central Nervous System; D002648:Child; D002675:Child, Preschool; D003037:Cobalt Radioisotopes; D003399:Craniotomy; D004806:Ependymoma / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D005260:Female; D006048:Gold Colloid, Radioactive / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006257:Head; D006801:Humans; D007278:Injections, Spinal; D008297:Male; D008527:Medulloblastoma / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D008910:Minnesota; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy; D009519:New York City; D011187:Posture; D011867:Radioisotope Teletherapy; D011877:Radionuclide Imaging; D011878:Radiotherapy / Q000379:methods; D013577:Syndrome
D003037:Cobalt Radioisotopes; D006048:Gold Colloid, Radioactive